ESC 365 - Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: observations from a tertiary care center

ESC Professional Premium Access

Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: observations from a tertiary care center

Session: Hypertrophic and other cardiomyopathies: miscellaneous findings

Topic: Pharmacotherapy

Speaker: Doctor M. Desai (Cleveland, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

16 presentations

1 follower

9 more presentations in this session

Sex-based differences in anatomical and hemodynamic parameters and outcomes in patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation

Speaker: Doctor A. Damlin (Stockholm, SE)

Clinical characteristics and burden of non-obstructive hypertrophic cardiomyopathy: a real-world survey in Italy and Spain

Speaker: Miss M. Lowe (Macclesfield, GB)

Symptoms trend in patients with obstructive hypertrophic cardiomyopathy treated with disopyramide.

Speaker: Doctor F. Borrelli (Napoly, IT)

Amplicon-based long-read sequencing is useful for confirming zygosity of DSG2 variants associated with Japanese ARVC.

Speaker: Doctor K. Sonoda (Suita, JP)

Relationship between six-minute walk distance and cardiopulmonary exercise testing in non-obstructive hypertrophic cardiomyopathy

Speaker: Doctor A. Bakalakos (London, GB)

Access the full session

Hypertrophic and other cardiomyopathies: miscellaneous findings

Speakers: Doctor M. Desai, Doctor A. Damlin, Miss M. Lowe, Doctor F. Borrelli, Doctor K. Sonoda...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources